ZA200005300B - Introduction of naked DNA or RNA encoding non-human vertrebrate peptide hormones or cytokines into a non-human vertebrate. - Google Patents

Introduction of naked DNA or RNA encoding non-human vertrebrate peptide hormones or cytokines into a non-human vertebrate.

Info

Publication number
ZA200005300B
ZA200005300B ZA200005300A ZA200005300A ZA200005300B ZA 200005300 B ZA200005300 B ZA 200005300B ZA 200005300 A ZA200005300 A ZA 200005300A ZA 200005300 A ZA200005300 A ZA 200005300A ZA 200005300 B ZA200005300 B ZA 200005300B
Authority
ZA
South Africa
Prior art keywords
human
vertrebrate
cytokines
introduction
naked dna
Prior art date
Application number
ZA200005300A
Other languages
English (en)
Inventor
Stephen Martin
Paul F Russell
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA200005300B publication Critical patent/ZA200005300B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA200005300A 1998-05-06 2000-09-29 Introduction of naked DNA or RNA encoding non-human vertrebrate peptide hormones or cytokines into a non-human vertebrate. ZA200005300B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8441898P 1998-05-06 1998-05-06

Publications (1)

Publication Number Publication Date
ZA200005300B true ZA200005300B (en) 2001-10-01

Family

ID=22184848

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200005300A ZA200005300B (en) 1998-05-06 2000-09-29 Introduction of naked DNA or RNA encoding non-human vertrebrate peptide hormones or cytokines into a non-human vertebrate.

Country Status (11)

Country Link
US (1) US20020111323A1 (pt)
EP (1) EP1075520A1 (pt)
JP (1) JP2002513811A (pt)
CN (1) CN1297481A (pt)
AU (1) AU3739999A (pt)
BR (1) BR9909918A (pt)
CA (1) CA2324650A1 (pt)
NO (1) NO20005567L (pt)
PL (1) PL345241A1 (pt)
WO (1) WO1999057275A1 (pt)
ZA (1) ZA200005300B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
EP1322655B1 (en) 2000-01-14 2007-11-14 The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services Oligodeoxynucleotide and its use to induce an immune response
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
US7354909B2 (en) * 2001-08-14 2008-04-08 The United States Of America As Represented By Secretary Of The Department Of Health And Human Services Method for rapid generation of mature dendritic cells
WO2003054161A2 (en) 2001-12-20 2003-07-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
US8263091B2 (en) 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
DE102007001370A1 (de) 2007-01-09 2008-07-10 Curevac Gmbh RNA-kodierte Antikörper
KR101383476B1 (ko) 2007-11-01 2014-04-11 아스테라스 세이야쿠 가부시키가이샤 면역억제 폴리펩티드 및 핵산
CA3036251A1 (en) 2016-09-15 2018-03-22 Leidos, Inc. Pd-1 peptide inhibitors
US10799555B2 (en) 2016-09-15 2020-10-13 Leidos, Inc. PD-1 peptide inhibitors
DK3758732T3 (da) 2018-02-27 2024-10-07 Leidos Inc PD-1-peptidinhibitorer
AU2020279371A1 (en) 2019-05-22 2021-12-23 Leidos, Inc. LAG 3 binding peptides
US11338040B2 (en) 2020-06-04 2022-05-24 Leidos, Inc. Immunomodulatory compounds
US11578102B2 (en) 2020-07-31 2023-02-14 Leidos, Inc. LAG3 binding peptides
JP2023548662A (ja) 2020-10-12 2023-11-20 レイドス， インコーポレイテッド 免疫調節性ペプチド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2092983A (en) * 1982-11-08 1984-05-17 Genentech Inc. Porcine growth hormone produced by recombinant dna technology
US5693622A (en) * 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
DE4303744A1 (de) * 1993-02-09 1994-08-11 Univ Autonoma De Nuevo Leon Mo Hundewachstumshormon
US6225290B1 (en) * 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation

Also Published As

Publication number Publication date
NO20005567D0 (no) 2000-11-03
EP1075520A1 (en) 2001-02-14
BR9909918A (pt) 2000-12-26
CN1297481A (zh) 2001-05-30
AU3739999A (en) 1999-11-23
NO20005567L (no) 2000-11-03
WO1999057275A1 (en) 1999-11-11
CA2324650A1 (en) 1999-11-11
PL345241A1 (en) 2001-12-03
US20020111323A1 (en) 2002-08-15
JP2002513811A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
ZA200005300B (en) Introduction of naked DNA or RNA encoding non-human vertrebrate peptide hormones or cytokines into a non-human vertebrate.
IL127477A0 (en) DNA sequences encoding phytases or ruminal microorganisms
EP0726940A4 (en) DNA ENCODING A TRIOL-POLYCETIDE-SYNTHASE
HUP0004115A2 (en) Novel nucleotide sequences coding for the pck gene
GB2332516B (en) Detecting nucleic acid sequences
HUP0103414A3 (en) Nucleic acid molecules encoding an amylosucrase
IL139011A0 (en) Gene coding for helimicine and use thereof
EP1047773A4 (en) CUBILIN PROTEIN, DNA SEQUENCES ENCODING CUBILIN AND THEIR USE
IL138208A0 (en) Gene encoding labyrinthin a marker for cancer
EP1117761A4 (en) MNR2 coding gene and method
PL340374A1 (en) Tanatin encoding gene
IL151375A0 (en) Nucleic acid molecule containing a neuregulin-1-associated gene and polypeptides encoded thereby
HUP0101697A3 (en) Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor
IL141305A0 (en) Dna constructs comprising protease encoding sequences or inhibitors thereof
HU9601302D0 (en) Dna sequences encoding porcine pancreatic carboxypeptidase b
IL112327A (en) Dna sequence encoding an organophosphate-resistant e3 esterase, an organophosphate-resistant e3 esterase encoded thereby and uses thereof
ZA200100332B (en) Novel nucleotide sequences coding for the ptsH gene.
EP1181316A4 (en) SNORF 36a AND SNORF 36b RECEPTORS ENCODING DNA
HK1049352A1 (zh) 一種新穎的脫氧核糖核酸編碼多肽prost-ets
GB9824357D0 (en) Protein and DNA coding therefor
EP1069186A4 (en) GENE ENCODING DESULFURASES
EP1063290A4 (en) NEW DICARBOYL REDUCTASE AND GENERAL CODING FOR IT
ZA9811058B (en) DNA encoding neospora dihydrofolate reductase-thymidylate synthase.
ZA200005845B (en) Gene encoding syntaxin interacting protein.
ZA992031B (en) Plasminogen-related gene B polypeptides.